Full Text
PMS22 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS. RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO

Abstract

Authors

X Gao S Hwang KT Carpiuc JM Stephens R Sato A Singh R Rivera E Garca H Bierschwale

Back to Volume 12, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×